What's New on the Blog
Pharmacists Poised to Play Larger Role in Uptake of Biosimilars
May 13, 2022
With the backing of new laws, retail pharmacists have considerable freedom to switch patients to FDA approved interchangeable biosimilars. While most are willing to use that freedom, according to a new report, unanswered questions remain.
New Medication Offers New Hope for Heart Patients
May 11, 2022
Things are looking up for patients who have an uncommon heart condition. The Food and Drug Administration last month approved a novel medication to treat obstructive hypertrophic cardiomyopathy.
Alzheimer’s Patients Dealt a Devastating Blow
May 9, 2022
With the finalization of a controversial draft policy, one federal agency dashed the hopes of millions of people living with Alzheimer’s and related dementias.
Innovation Puts Patients Back in Charge
May 6, 2022
By Robert Fekete, MD - Getting tardive dyskinesia is devastating for mental health patients who are getting back on track.
The Value of Innovation Policy Forum in Five Quotes
May 5, 2022
What is medical innovation worth? To explore this question, the Institute for Patient Access recently convened health policy and patient advocacy professionals for the Value of Innovation Policy Forum in Washington, D.C.
Latest
Policy Papers
April 2022
April 2022
March 2022
Policy Summits
March 2022
December 2021
